![]() |
||||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Go back to clinical information and images Diagnosis: IgA Nephropathy (with subendothelial deposits and IgG co-deposition) The development of immunoglobulin A (IgA) nephropathy (IgAN) appears to require an autoantibody (IgG or IgA) against the autoantigen galactose-deficient IgA1. Pathologically, IgAN is an IgA dominant or codominant immune complex–mediated glomerulonephritis that may have codeposition of IgG by immunofluorescence. In a multicenter IgAN cohort, IgG co-deposition and location of glomerular immune deposits in the peripheral capillary walls (PCWs) were both associated with greater histologic activity on renal biopsy, but only the location of glomerular immune deposits was significantly associated with definitive renal outcomes. Patients with immune deposits in the PCWs in addition to the mesangium had greater proteinuria at diagnosis and were at increased risk for ESRD, transplant, death and/or doubling of SCr (Alvarado AS, et al. Location of glomerular immune deposits, not codeposition of immunoglobulin G, influences definitive renal outcomes in immunoglobulin A nephropathy. Nephrol Dial Transplant. 2018 Jul 1;33(7):1168-1175. [PubMed link]) See the chapter: IgA Nephropathy of our Tutorial. Go back to clinical information and images References
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||